Sompraz HP
Loading drug information...
Failed to Load Drug Information
Please check your internet connection and try again.
Last updated: June 2025
For educational purposes only
Clinical Reference
# Sompraz HP
## Overview
- **Classification**: Combination therapy (Proton Pump Inhibitor + Penicillin Antibiotic + Macrolide Antibiotic).
- **Mechanism**: **Esomeprazole** reduces gastric acid secretion. **Amoxicillin** inhibits bacterial cell wall synthesis. **Clarithromycin** inhibits bacterial protein synthesis. Together, they effectively eradicate *Helicobacter pylori*.
## Primary Indications
1. **_H. pylori_ Eradication**: Treatment of *Helicobacter pylori* infection to reduce the risk of duodenal ulcer recurrence.
## Adult Dosing
### Standard Dosing
**_H. pylori_ Eradication**
- **Dose**: **Esomeprazole 20 mg**, **Amoxicillin 750 mg**, **Clarithromycin 500 mg**. (All components of the kit taken together).
- **Frequency**: **Twice daily** (every 12 hours).
- **Route**: Oral.
- **Duration**: **10-14 days** (follow local guidelines/prescribing information).
- **Special Considerations**: Take with or without food, but consistently. Ensure all three medications are taken at each dosing interval.
### Dose Adjustments
- **Renal Impairment**:
- **Clarithromycin**: CrCl <30 mL/min, reduce clarithromycin dose by **50%** (e.g., **250 mg twice daily**) or extend interval.
- Severe impairment: Avoid clarithromycin if possible or use alternative regimens.
- No specific adjustment for Esomeprazole; Amoxicillin may need adjustment in severe cases.
- **Hepatic Impairment**: Use with caution.
- **Clarithromycin**: Contraindicated in severe hepatic impairment with concurrent renal impairment.
- **Esomeprazole**: No adjustment needed in mild-moderate; severe impairment requires caution.
- **Elderly Patients**: No specific dose adjustment generally needed, but monitor renal function closely due to clarithromycin.
## Pediatric Dosing
### Neonates (0-28 days)
- **Not recommended**. Safety and efficacy of this fixed combination kit are not established.
- **Special Notes**: *H. pylori* eradication is rarely indicated in neonates.
### Infants (1-12 months)
- **Not recommended**. Fixed-dose combination kit is not suitable due to inability to adjust component doses by weight.
- **Special Notes**: Individual drug components would be dosed based on weight if *H. pylori* treatment is necessary.
### Children (1-12 years)
- **Not recommended as a fixed kit**. The combination kit cannot be adjusted for pediatric weights.
- **If individual components are used for _H. pylori_**:
- **Esomeprazole**: **1 mg/kg/day** divided **BID** (max **20-40 mg/day**).
- **Amoxicillin**: **50 mg/kg/day** divided **BID** (max **1000 mg/dose** or **3000 mg/day**).
- **Clarithromycin**: **15 mg/kg/day** divided **BID** (max **500 mg/dose** or **1000 mg/day**).
- **Duration**: **10-14 days**.
- **Special Notes**: Always use individual drug components and dose based on child's weight.
### Adolescents (13-18 years)
- **Dose**: Generally follows **adult dosing** if weight is ≥ **40 kg**.
- **Maximum**: **Adult dose** (Esomeprazole 20 mg, Amoxicillin 750 mg, Clarithromycin 500 mg **BID**).
- **Special Notes**: Consider individual drug components for weight-based dosing if the adolescent is small.
## Safety Information
### Contraindications
- **Absolute**: Hypersensitivity to esomeprazole, amoxicillin, other penicillins, clarithromycin, or other macrolides.
- **Absolute**: History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
- **Absolute**: Concomitant use with **pimozide, cisapride, ergotamine, dihydroergotamine, colchicine, ticagrelor, ranolazine** (due to clarithromycin interactions).
- **Absolute**: Severe renal impairment with concurrent hepatic impairment (clarithromycin).
- **Absolute**: Myasthenia Gravis (clarithromycin can exacerbate symptoms).
### Common Adverse Effects
- **Very Common (>10%)**: Diarrhea, Nausea, Headache.
- **Common (1-10%)**: Abdominal pain, Taste perversion (dysgeusia - clarithromycin), Vomiting, Dyspepsia, Flatulence, Rash.
- **Serious but Rare**: *Clostridioides difficile*-associated diarrhea (CDAD), QT prolongation (clarithromycin), Hepatotoxicity, Pancreatitis, Anaphylaxis, Stevens-Johnson syndrome, Interstitial nephritis.
### Key Drug Interactions
- **Warfarin**: Increased INR/bleeding risk (clarithromycin). **Monitor INR closely**.
- **Statins (e.g., Simvastatin, Lovastatin)**: Increased risk of myopathy/rhabdomyolysis (clarithromycin - CYP3A4 inhibition). **Avoid co-administration** or use alternative statin (e.g., pravastatin).
- **Oral Contraceptives**: Potential decreased efficacy (amoxicillin). Advise **backup contraception**.
- **Antivirals (e.g., Atazanavir, Nelfinavir)**: Reduced absorption/efficacy due to PPI. **Avoid concurrent use** if possible.
- **Methotrexate**: Increased levels/toxicity (esomeprazole, amoxicillin). **Monitor for toxicity**.
- **Drugs metabolized by CYP3A4 (e.g., Midazolam, Tacrolimus, Carbamazepine)**: Increased levels/toxicity (clarithromycin). **Monitor drug levels**, adjust dose.
- **Digoxin**: Increased digoxin levels (clarithromycin). **Monitor digoxin levels**.
- **QT-prolonging drugs**: Increased risk of Torsades de Pointes (clarithromycin). **Avoid concurrent use** if possible.
## Monitoring & Follow-up
- **Before Treatment**: Assess drug allergies (penicillin, macrolides).
- **During Treatment**: Monitor for signs of *C. difficile* infection (severe diarrhea, abdominal pain).
- **Clinical Signs**: Watch for persistent GI symptoms, rash, signs of hepatic dysfunction (jaundice, dark urine), signs of allergic reaction.
- **Post-Treatment**: Confirm *H. pylori* eradication with urease breath test or stool antigen test **4-6 weeks** after completing therapy.
## Clinical Pearls
- 💡 **Compliance is critical**: Emphasize taking all three medications twice daily for the full duration to maximize eradication success and minimize resistance development.
- 💡 **Taste disturbance**: Clarithromycin can cause a metallic or bitter taste; reassure patients this is common and usually resolves after therapy.
- 💡 **Food intake**: While esomeprazole is often taken before food, *H. pylori* regimens typically suggest taking all components consistently (with or without food, but usually with food can help reduce GI upset). Follow specific kit instructions.
- 💡 **Diarrhea**: Common. Differentiate between antibiotic-associated diarrhea and *C. difficile* infection.
- 💡 **Penicillin allergy**: Always confirm allergy history. If severe, a different *H. pylori* regimen is required.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.